Xu et al. reported that methamphetamine exposure disrupts insulin signaling, leading to brain insulin resistance, as evidenced by the downregulation of insulin receptor substrate-1 and AKT serine 473, along with activation of GSK-3β [35]. The gene discussed is GSK3B; the disease is Insulin resistance.